The board meeting for Ideaya Biosciences Inc is scheduled for today, for the purpose of Morgan Stanley 24th Annual Global Healthcare ConferenceSee details
Ideaya Biosciences Inc has a share price target of US$ 52, revenue growth forecast of -82.0%, and profit growth estimate of -280.0% for FY26, based on top 15 analyst calls.